1. Home
  2. AMLX

AMLX

Amylyx Pharmaceuticals Inc.

Logo Amylyx Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Founded: 2014 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 177.6M IPO Year: 2022
Target Price: $11.00 AVG Volume (30 days): 3.2M
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.70 EPS Growth: N/A
52 Week Low/High: $2.07 - $31.77 Next Earning Date: 05-09-2024
Revenue: $380,786,000 Revenue Growth: 1612.94%
Revenue Growth (this year): -72.6% Revenue Growth (next year): 224.60%

Share on Social Networks: